The gastric balloon is billed as an alternative for people with obesity who don’t want bariatric surgery or weight-loss drugs. How does it work and does it get the same results?
Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wegovy's launch had brought, after the drugmaker said its next-generation obesity drug CagriSema underperformed Eli ...
Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...
Eli Lilly (LLY) stock is in focus as the company ramps up inventory for its weight loss pill orforglipron as its FDA approval nears in Q2 2026. Read more here.
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Ozempic is the brand-name version of ...
PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: ...
In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...
A long-term study found that while a ketogenic diet prevented weight gain, it also triggered major metabolic problems. Mice developed fatty liver disease, abnormal blood fats, and an impaired ability ...
For many Americans, the cost of trying to lose weight extends well beyond the scale. A new poll of 2,000 U.S. adults actively trying to lose weight found the average respondent spent $12,308 in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results